Cargando…

Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease

The prevalence of hepatitis C virus (HCV) infection amongst patients with chronic kidney disease (CKD) and end-stage renal disease exceeds that of the general population. In addition to predisposing to the development of cirrhosis and hepatocellular carcinoma, infection with HCV has been associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ladino, Marco, Pedraza, Fernando, Roth, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504358/ https://www.ncbi.nlm.nih.gov/pubmed/28740594 http://dx.doi.org/10.4254/wjh.v9.i19.833

Ejemplares similares

Kidney Transplantation From a Hepatitis C Virus–Infected Donor Into an Uninfected Recipient: Ready for Prime Time?
por: Pagan, Javier, et al.
Publicado: (2020)

Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2022)

Neurological and psychiatric effects of hepatitis C virus infection
por: Faccioli, Jessica, et al.
Publicado: (2021)

Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults
por: Laiwatthanapaisan, Ratchapong, et al.
Publicado: (2021)

Treatment of hepatitis B virus infection in children and adolescents
por: Stinco, Mariangela, et al.
Publicado: (2021)

Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
por: Irshad, Mohammad, et al.
Publicado: (2017)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

Metabolic aspects of hepatitis C virus
por: El-Kassas, Mohamed, et al.
Publicado: (2022)

Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment
por: Yin, Guo-Qing, et al.
Publicado: (2022)

Chronic hepatitis B-associated liver disease in the context of human immunodeficiency virus co-infection and underlying metabolic syndrome
por: Amponsah-Dacosta, Edina, et al.
Publicado: (2020)

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection
por: Cloherty, Gavin, et al.
Publicado: (2016)

Hepatitis C virus treatment failure: Clinical utility for testing resistance-associated substitutions
por: Ridruejo, Ezequiel, et al.
Publicado: (2021)

Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)

Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
por: Shi, Yi-Xian, et al.
Publicado: (2016)

Direct antiviral agents in hepatitis C virus related liver disease: Don’t count the chickens before they’re hatched
por: Compagnoni, Stella, et al.
Publicado: (2021)

Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease
por: Khoo, Tiffany, et al.
Publicado: (2021)

Screening and prevention of hepatitis C virus reactivation during chemotherapy
por: Li, Yuan-Rung, et al.
Publicado: (2021)

Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022)

Prevention of vertical transmission of hepatitis B virus infection
por: Veronese, Piero, et al.
Publicado: (2021)

Neurological manifestations of hepatitis E virus infection: An overview
por: Jha, Ashish Kumar, et al.
Publicado: (2021)

Human immune repertoire in hepatitis B virus infection
por: Zhan, Qiao, et al.
Publicado: (2021)

Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies
por: Gore, M E, et al.
Publicado: (2011)

Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment
por: Spera, Anna Maria
Publicado: (2022)

Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
por: Omran, Dalia, et al.
Publicado: (2018)

Hepatitis C virus micro-elimination: Where do we stand?
por: Mangia, Alessandra, et al.
Publicado: (2021)

Innate immune recognition and modulation in hepatitis D virus infection
por: Jung, Stephanie, et al.
Publicado: (2020)

Hepatitis delta virus: From infection to new therapeutic strategies
por: Niro, Grazia A, et al.
Publicado: (2021)

Kidney transplant from donors with hepatitis B: A challenging treatment option
por: Srisuwarn, Praopilad, et al.
Publicado: (2021)

Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID-19 compared with standard of care? A literature review
por: Spera, Anna Maria
Publicado: (2021)

Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
por: Crismale, James F, et al.
Publicado: (2019)

Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice
por: Marascio, Nadia, et al.
Publicado: (2022)

Hepatitis B virus-persistent infection and innate immunity defect: Cell-related or virus-related?
por: Tang, Jian, et al.
Publicado: (2018)

Practical insights into chronic management of hepatic Wilson’s disease
por: Lynch, Erica Nicola, et al.
Publicado: (2022)

Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis
por: Wu, Ya-Li, et al.
Publicado: (2019)

Kidney disease in patients with chronic liver disease: Does sex matter?
por: Cooper, Katherine M, et al.
Publicado: (2023)

Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
por: Kamal, Ahmed, et al.
Publicado: (2022)

Impact of coronavirus disease 2019 on prevention and elimination strategies for hepatitis B and hepatitis C
por: Rehman, Syed Tabish, et al.
Publicado: (2021)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Form confers function: Case of the 3’X region of the hepatitis C virus genome
por: Dutkiewicz, Mariola, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ftkj1g0m0b3dgn1tb025ituv56